Karl Otfried Schwab

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 3

Top Topics

Randomized Controlled Trial

Recombinant Human

Smoking Cessation

Clinical Practice

Top Venues

Drug design, development and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Sandro Loche, Shankar Kanumakala, Philippe F Backeljauw, Karl Otfried Schwab, Alfonso María Lechuga-Sancho, Altaher Esmael, Dragan Urosevic, Anca Boldea, Markus Zabransky
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study. Drug design, development and therapy 18 (2024)
Sandro Loche, Shankar Kanumakala, Philippe F Backeljauw, Karl Otfried Schwab, Alfonso María Lechuga-Sancho, Altaher Esmael, Dragan Urosevic, Anca Boldea, Markus Zabransky
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study. Drug design, development and therapy 18 (2024)
Sandro Loche, Shankar Kanumakala, Philippe F Backeljauw, Karl Otfried Schwab, Alfonso María Lechuga-Sancho, Altaher Esmael, Dragan Urosevic, Anca Boldea, Markus Zabransky
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study. Drug design, development and therapy 18 (2024)